Search Results

There are 14397 results for: content related to: Global 3-dimensional approach to natural rejuvenation: recommendations for perioral, nose, and ear rejuvenation

  1. Global, 3-dimensional approach to natural rejuvenation: part 1 – recommendations for volume restoration and the periocular area

    Journal of Cosmetic Dermatology

    Volume 11, Issue 4, December 2012, Pages: 279–289, Hervé Raspaldo, Véronique Gassia, François-Rene Niforos and Thierry Michaud

    Version of Record online : 23 NOV 2012, DOI: 10.1111/jocd.12003

  2. Evaluation of headache relief with cosmetic onabotulinumtoxinA injections

    Journal of Cosmetic Dermatology

    Volume 13, Issue 3, September 2014, Pages: 224–231, Neal D Goldman, Leighanne H Dorton, Kristin K Marcum, Ryan M Gilbert and Laura F Sandoval

    Version of Record online : 6 SEP 2014, DOI: 10.1111/jocd.12098

  3. You have free access to this content
    OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 50, Issue 6, June 2010, Pages: 921–936, David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans-Christoph Diener and Mitchell F. Brin

    Version of Record online : 7 MAY 2010, DOI: 10.1111/j.1526-4610.2010.01678.x

  4. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines

    Journal of Cosmetic Dermatology

    Volume 11, Issue 4, December 2012, Pages: 267–271, Welf Prager and Thomas Rappl

    Version of Record online : 2 OCT 2012, DOI: 10.1111/jocd.12001

  5. OnabotulinumtoxinA therapy for compensatory hyperhidrosis

    Journal of Cosmetic Dermatology

    Volume 12, Issue 3, September 2013, Pages: 232–234, Jessica A Adefusika and Jerry D Brewer

    Version of Record online : 1 SEP 2013, DOI: 10.1111/jocd.12049

  6. Dose response with onabotulinumtoxinA for post-stroke spasticity: A pooled data analysis

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 209–215, Stuart A. Yablon, Mitchell F. Brin, Amanda M. VanDenburgh, Jihao Zhou, Susan M. Garabedian-Ruffalo, Susan Abu-Shakra and Frederick C. Beddingfield III

    Version of Record online : 19 OCT 2010, DOI: 10.1002/mds.23426

  7. You have full text access to this OnlineOpen article
    Development of onabotulinumtoxinA for chronic migraine

    Annals of the New York Academy of Sciences

    Volume 1329, Issue 1, November 2014, Pages: 67–80, Scott M. Whitcup, Catherine C. Turkel, Ronald E. DeGryse and Mitchell F. Brin

    Version of Record online : 18 AUG 2014, DOI: 10.1111/nyas.12488

  8. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 51, Issue 9, October 2011, Pages: 1358–1373, Sheena K. Aurora, Paul Winner, Marshall C. Freeman, Egilius L. Spierings, Jessica O. Heiring, Ronald E. DeGryse, Amanda M. VanDenburgh, Marissa E. Nolan and Catherine C. Turkel

    Version of Record online : 29 AUG 2011, DOI: 10.1111/j.1526-4610.2011.01990.x

  9. Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 51, Issue 10, November/December 2011, Pages: 1573–1577, Paul L. Durham and Roger Cady

    Version of Record online : 14 NOV 2011, DOI: 10.1111/j.1526-4610.2011.02022.x

  10. You have free access to this content
    A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue 10, November/December 2009, Pages: 1466–1478, Ninan T. Mathew and Sayyed Farhan A. Jaffri

    Version of Record online : 3 NOV 2009, DOI: 10.1111/j.1526-4610.2009.01566.x

  11. Difficult Urination Does Not Affect the Successful Outcome after 100U OnabotulinumtoxinA Intravesical Injection in Patients with Idiopathic Detrusor Overactivity

    LUTS: Lower Urinary Tract Symptoms

    Volume 4, Issue 1, January 2012, Pages: 29–34, Yih-Chou CHEN and Hann-Chorng KUO

    Version of Record online : 12 SEP 2011, DOI: 10.1111/j.1757-5672.2011.00102.x

  12. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  13. You have full text access to this OnlineOpen article
    Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 10, November/December 2014, Pages: 1565–1573, John F. Rothrock, Lisa M. Bloudek, Timothy T. Houle, Diane Andress-Rothrock and Sepideh F. Varon

    Version of Record online : 8 OCT 2014, DOI: 10.1111/head.12456

  14. An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 2, February 2014, Pages: 269–277, Roger Cady, Ira Turner, Kent Dexter, M. E. Beach, Ryan Cady and Paul Durham

    Version of Record online : 22 OCT 2013, DOI: 10.1111/head.12250

  15. You have full text access to this OnlineOpen article
    OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

    Acta Neurologica Scandinavica

    Volume 129, Issue 1, January 2014, Pages: 61–70, S. K. Aurora, D. W. Dodick, H.-C. Diener, R. E. DeGryse, C. C. Turkel, R. B. Lipton and S. D. Silberstein

    Version of Record online : 20 SEP 2013, DOI: 10.1111/ane.12171

  16. The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: A systematic review and meta-analysis

    Neurourology and Urodynamics

    Volume 34, Issue 5, June 2015, Pages: 413–419, Yuanshan Cui, Xin Zhou, Huantao Zong, Huilei Yan and Yong Zhang

    Version of Record online : 28 MAR 2014, DOI: 10.1002/nau.22598

  17. You have free access to this content
    Botulinum toxin type A for the treatment of lower urinary tract disorders

    International Journal of Urology

    Volume 19, Issue 3, March 2012, Pages: 202–215, Teruhiko Yokoyama, Michael B Chancellor, Keiji Oguma, Yumiko Yamamoto, Tomonori Suzuki, Hiromi Kumon and Atsushi Nagai

    Version of Record online : 6 JAN 2012, DOI: 10.1111/j.1442-2042.2011.02946.x

  18. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB)

    Neurourology and Urodynamics

    Volume 33, Issue S3, July 2014, Pages: S26–S31, Francisco Cruz and Victor Nitti

    Version of Record online : 8 JUL 2014, DOI: 10.1002/nau.22630

  19. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  20. Concurrent OnabotulinumtoxinA Treatment of Cervical Dystonia and Concomitant Migraine

    Headache: The Journal of Head and Face Pain

    Volume 52, Issue 8, September 2012, Pages: 1219–1225, Paul K. Winner, Carl H. Sadowsky, Walter C. Martinez, Jose A. Zuniga and Ashley Poulette

    Version of Record online : 18 MAY 2012, DOI: 10.1111/j.1526-4610.2012.02164.x